Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Naseri M et al. – Favorable response to steroid and cyclophosphamide treatment is a protective factor against disease progression to end stage renal disease and resistance to these drugs imply a poor prognosis. For making any definite conclusion concerning response to cyclosporine treatment and prognosis, similar studies with a larger sample are required.

Related Articles

Dystroglycan in the Diagnosis of FSGS
Clinical Journal of the American Society of Nephrology, 11/16/09    Relevance Score: 87%

Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study
Nephrology Dialysis Transplantation, 10/07/09    Relevance Score: 85%

Development of Focal Segmental Glomerulosclerosis after Anabolic Steroid Abuse
Journal of the American Society of Nephrology, 11/18/09    Relevance Score: 80%

Adequate use of allele frequencies in Hispanics--a problem elucidated in nephrotic syndrome
Pediatric Nephrology, 11/04/09    Relevance Score: 80%

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation
Transplant International, 10/02/09    Relevance Score: 80%

Today in Chronic Dz/Renal Failure...keeping you current

Uromodulin Levels Associate with a Common UMOD Variant and Risk for Incident CKD
Journal of the American Society of Nephrology, 12/08/09

Dietary Fructose Inhibits Intestinal Calcium Absorption and Induces Vitamin D Insufficiency in CKD
Journal of the American Society of Nephrology, 12/08/09

The association of renal impairment with all-cause and cardiovascular disease mortality
Nephrology Dialysis Transplantation, 12/08/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address